Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Latanoprost

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    58 result(s) found for: Latanoprost. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2013-002261-18 Sponsor Protocol Number: M05-2013 Start Date*: 2013-08-21
    Sponsor Name:Synphora AB
    Full Title: A randomized, double-blind, placebo-controlled, parallel group study to determine the efficacy, the duration of action, and safety of latanoprost in patients with Menière’s disease
    Medical condition: Menière´s disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2014-005468-14 Sponsor Protocol Number: OPHT-081214 Start Date*: 2015-02-24
    Sponsor Name:Medical University of Vienna, Department of Clinical Pharmacology
    Full Title: Latanoprost preserved versus unpreserved: effect on tear film thickness as measured with OCT
    Medical condition: glaucoma and ocular hypertension
    Disease: Version SOC Term Classification Code Term Level
    19.1 10015919 - Eye disorders 10018307 Glaucoma and ocular hypertension HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-000844-15 Sponsor Protocol Number: A6111139 Start Date*: 2008-10-29
    Sponsor Name:Pfizer Inc. 235 East 42nd Street, NEW YORK, NY 10017. US
    Full Title: A PHASE 1, OPEN-LABEL STUDY OF LATANOPROST ACID PLASMA CONCENTRATIONS IN PEDIATRIC AND ADULT GLAUCOMA PATIENTS TREATED WITH LATANOPROST 0.005%
    Medical condition: GLAUCOMA
    Disease: Version SOC Term Classification Code Term Level
    9.1 10018304 Glaucoma LLT
    Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) ES (Completed) PT (Completed) DK (Completed) PL (Ongoing) IT (Completed) GR (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2010-021456-25 Sponsor Protocol Number: LAT-SOP-01-2010 Start Date*: 2011-03-15
    Sponsor Name:Laboratorios SOPHIA, S.A. de C.V.
    Full Title: “ESTUDIO CLÍNICO DE SEGURIDAD PARA COMPARAR UNA SOLUCIÓN TÓPICA OFTÁLMICA DE GAAP OFTENO® (LATANOPROST AL 0.005%) FRENTE A XALATAN® (LATANOPROST AL 0.005%) COMO PRODUCTO DE REFERENCIA, EN PACIENTES...
    Medical condition: Pacientes con glaucoma primario de ángulo abierto y/o hipertensión ocular
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-005379-10 Sponsor Protocol Number: HUS_MON_2014-01 Start Date*: 2015-05-18
    Sponsor Name:Emiliano Hernández Galilea
    Full Title: Study of tear osmolarity and Quality of Life on patients treated with unpreserved latanoprost 0.005%
    Medical condition: Chronic open angle glaucoma and ocular hypertension
    Disease: Version SOC Term Classification Code Term Level
    17.1 10015919 - Eye disorders 10018307 Glaucoma and ocular hypertension HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-018067-27 Sponsor Protocol Number: SynergyStudy Start Date*: 2010-05-10
    Sponsor Name:Glaukos Corporation
    Full Title: Evaluación cruzada prospectiva en abierto del iStent® (GTS400) en pacientes con glaucoma primario de ángulo abierto (Synergy Study)
    Medical condition: Glaukoma
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-005314-29 Sponsor Protocol Number: QTM/OMN-0115 Start Date*: 2016-03-02
    Sponsor Name:OMNIVISION GmbH
    Full Title: Randomized, open-label, two parallel group clinical trial, conducted under blinding evaluator conditions to compare the efficacy and tolerability of preservative-free formulation of Latanoprost 50µ...
    Medical condition: Open Angle Glaucoma or Ocular Hypertension
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2019-001642-18 Sponsor Protocol Number: WP3 Start Date*: 2019-12-05
    Sponsor Name:Department of Ophthalmology, Rigshospitalet-Glostrup
    Full Title: Effect on the ocular surface when treating glaucoma with eye drops: an investigation of the conjunctival goblet cells
    Medical condition: Open angular glaucoma and ocular hypertension
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2013-001634-17 Sponsor Protocol Number: MAF/ISS/OPH/GLA/035 Start Date*: 2013-10-30
    Sponsor Name:AZIENDA OSPEDALIERA S. PAOLO
    Full Title: LONG-TERM 24-HOUR INTRAOCULAR PRESSURE CONTROL AND PROGRESSION RATE OBTAINED WITH THE ASSOCIATION OF COMBIGAN IN THE MORNING AND GANFORT IN THE EVENING COMPARED WITH LATANOPROST IN HIGH RISK OPEN-A...
    Medical condition: Patients with glaucoma open angle or glaucoma exfoliative with high risknewly diagnosed and untreated.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2021-005170-25 Sponsor Protocol Number: GNT-01-21 Start Date*: 2022-02-10
    Sponsor Name:Genetic S.p.A.
    Full Title: PHASE III MULTICENTER RANDOMIZED TRIAL OF PRESERVATIVE FREE LATANOPROST 50µG/ML VS XALATAN IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION
    Medical condition: Patients with Open-Angle Glaucoma or ocular hypertension
    Disease: Version SOC Term Classification Code Term Level
    23.1 100000004853 10084293 Unilateral glaucoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-000142-19 Sponsor Protocol Number: VT-1201 Start Date*: 2013-05-31
    Sponsor Name:VISIOTACT PHARMA
    Full Title: -
    Medical condition: -
    Disease: Version SOC Term Classification Code Term Level
    16.0 10015919 - Eye disorders 10018307 Glaucoma and ocular hypertension HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-005222-29 Sponsor Protocol Number: LT2347-PIII-12/13 Start Date*: 2014-12-19
    Sponsor Name:Laboratoires THÉA
    Full Title: Efficacy and Safety assessment of fixed combination unpreserved Latanoprost eye drops and Timolol 0.5% (T2347) versus Xalacom® in ocular hypertensive or glaucomatous patients. Phase III, internati...
    Medical condition: glaucoma, ocular hypertension
    Disease: Version SOC Term Classification Code Term Level
    17.0 10015919 - Eye disorders 10018307 Glaucoma and ocular hypertension HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) BE (Completed) GB (Completed) ES (Completed) EE (Completed) HU (Ongoing) LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004543-30 Sponsor Protocol Number: A6111137 Start Date*: 2008-11-24
    Sponsor Name:Pfizer Inc. 235 East 42nd Street, NEW YORK, NY 10017. US
    Full Title: A PHASE 3 PROSPECTIVE, RANDOMIZED, DOUBLE MASKED, 12 WEEK, PARALLEL GROUP STUDY EVALUATING THE EFFICACY AND SAFETY OF LATANOPROST AND TIMOLOL IN PAEDIATRIC SUBJECTS WITH GLAUCOMA
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    9.1 10010486 Congenital glaucoma LLT
    Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) ES (Completed) IT (Completed) SI (Completed) BE (Completed) PT (Completed) FR (Completed) CZ (Completed) SK (Completed) DK (Prematurely Ended) GR (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2010-022178-14 Sponsor Protocol Number: 659 Start Date*: 2011-02-14
    Sponsor Name:Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH/Bausch & Lomb
    Full Title: A Randomized, Multicenter, Single-Masked, Parallel-Group Dose Finding Study Comparing the Safety and Efficacy of BOL-303259-X (0.006%, 0.012%, 0.024% and 0.040%) to Latanoprost 0.005% in Subjects w...
    Medical condition: Open Angle Glaucoma or Ocular Hypertension
    Disease: Version SOC Term Classification Code Term Level
    14.0 10015919 - Eye disorders 10018307 Glaucoma and ocular hypertension HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed) CZ (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2009-012799-28 Sponsor Protocol Number: MAF-AGN-OPH-GLA-010 Start Date*: 2009-11-11
    Sponsor Name:Allergan
    Full Title: Estudio Piloto de tres meses, multicéntrico, enmascarado para el Investigador, para evaluar la eficacia y la seguridad de una combinación fija de Bimatoprost/Timolol versus Latanoprost en pacientes...
    Medical condition: Treatment-Naïve Patients with Open Angle Glaucoma at High Risk of Glaucomatous Progression. Pacientes Naïve con glaucoma de ángulo abierto con alto riesgo de progresión glaucomatosa.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) PT (Completed)
    Trial results: View results
    EudraCT Number: 2008-000780-42 Sponsor Protocol Number: Latanoprost 1/2007 Start Date*: 2008-02-20
    Sponsor Name:PH&T SPA
    Full Title: Evaluation of the therapeutic equivalence of latanoprost PK and Xalatan. Double blind randomized clinical trial in subjects affected by open angle glaucoma or intraocular hypertension.
    Medical condition: Subjects affected by glaucoma or intraocular hypertension.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10015919 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-002601-30 Sponsor Protocol Number: QTM/OMN0111 Start Date*: 2011-09-26
    Sponsor Name:OMNIVISION GmbH
    Full Title: A COMPARISON OF LATANOPROST 50µg/ml EYE DROPS vs. XALATAN EYE DROPS IN THE TREATMENT OF OPEN ANGLE GLAUCOMA: AN OPEN, RANDOMIZED, CLINICAL TRIAL
    Medical condition: Open angle glaucoma
    Disease: Version SOC Term Classification Code Term Level
    14.0 10015919 - Eye disorders 10030856 Open-angle glaucoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-002122-10 Sponsor Protocol Number: RDR342 Start Date*: 2008-10-17
    Sponsor Name:RDR Pharma GmbH
    Full Title: Comparison of the Clinical Efficacy and Tolerability of Latanoprost RDR 0.005% Eye Drops Test Formulation of RDR Pharma GmbH, Germany, for the Treatment of Ocular Hypertension and Primary Open Angl...
    Medical condition: Ocular Hypertension (IOP>22 mmHg), Primary Open Angle Glaucoma (mean defect between 0 and -12 db in a visual field)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030043 Ocular hypertension LLT
    9.1 10036719 Primary open angle glaucoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) LT (Prematurely Ended) BG (Completed) LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004060-24 Sponsor Protocol Number: Glaucoma Xalacam /Combigan Start Date*: 2005-11-24
    Sponsor Name:Department of Clinical Pharmacology
    Full Title: A double-masked randomized cross-over study comparing the effect of Xalacom (latanoprost/timolol) and Combigan (brimonidine/timolol) fixed combination on intraocular pressure and ocular blood flow ...
    Medical condition: Glaucoma
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2011-005339-15 Sponsor Protocol Number: QTM/OMN0211 Start Date*: 2012-02-03
    Sponsor Name:Omnivision GmbH
    Full Title: Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of the Fixed Combin...
    Medical condition: Primary open angle glaucoma or intraocular hypertension
    Disease: Version SOC Term Classification Code Term Level
    14.0 10015919 - Eye disorders 10030043 Ocular hypertension PT
    14.0 10015919 - Eye disorders 10036719 Primary open angle glaucoma LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 21:44:57 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA